Page last updated: 2024-12-06

iodecol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID71247
CHEMBL ID2104392
SCHEMBL ID380986
MeSH IDM0117253

Synonyms (13)

Synonym
iodecimol
5-[[3-[3,5-bis(1,3-dihydroxypropan-2-ylcarbamoyl)-n-(2-hydroxyethyl)-2,4,6-triiodoanilino]-3-oxopropanoyl]-(2-hydroxyethyl)amino]-1-n,3-n-bis(1,3-dihydroxypropan-2-yl)-2,4,6-triiodobenzene-1,3-dicarboxamide
81045-33-2
iodecimol [inn-latin]
iodecimol [inn]
iodecol
5,5'-(malonylbis((2-hydroxyethyl)imino))bis(n,n'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodoisophthalamide)
unii-3sdg4rsp99
3sdg4rsp99 ,
CHEMBL2104392
DTXSID50230870
SCHEMBL380986
Q27257977

Research Excerpts

Actions

ExcerptReferenceRelevance
"Iodecol caused less increase of peak velocity of pressure rise and systolic blood pressure than Iopamidol."( [Acute cardiac side effects of iodecol, a new nonionic dimer roentgen contrast medium, in intracoronary injection].
Hellige, G; Hoeft, A; Hoeft, T; Kober, G; Korb, H; Schräder, R; Wolpers, HG, 1985
)
1.28

Toxicity

ExcerptReferenceRelevance
"Selective vertebral angiography was performed in 28 rabbits in order to compare the adverse effects of two monomeric (metrizamide, iohexol) and two dimeric (iodecol, 2-5410-3) non-ionic water-soluble contrast media."( The toxicity of non-ionic water-soluble contrast media in selective vertebral angiography. An experimental study in rabbits with special reference to the difference between monomeric and dimeric compounds.
Aulie, A; Skalpe, IO, 1985
)
0.47
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]